Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells by unknown
Wang et al. Journal of Nanobiotechnology  (2014) 12:58 
DOI 10.1186/s12951-014-0058-0RESEARCH Open AccessFluorescent carbon dots as an efficient siRNA
nanocarrier for its interference therapy in gastric
cancer cells
Qing Wang1,2†, Chunlei Zhang2†, Guangxia Shen2*, Huiyang Liu2, Hualin Fu2 and Daxiang Cui1,2*Abstract
Background: Fluorescent carbon dots (Cdots) have attracted increasing attention due to their potential applications in
sensing, catalysis, and biomedicine. Currently, intensive research has been concentrated on the synthesis and
imaging-guided therapy of these benign photoluminescent materials. Meanwhile, Cdots have been explored as
nonviral vector for nucleic acid or drug delivery by chemical modification on purpose.
Results: We have developed a microwave assisted one-step synthesis of Cdots with citric acid as carbon source
and tryptophan (Trp) as both nitrogen source and passivation agent. The Cdots with uniform size show superior
water solubility, excellent biocompatibility, and high quantum yield. Afterwards, the PEI (polyethylenimine)-adsorbed
Cdots nanoparticles (Cdots@PEI) were applied to deliver Survivin siRNA into human gastric cancer cell line MGC-803.
The results have confirmed the nanocarrier exhibited excellent biocompatibility and a significant increase in cellular
delivery of siRNA, inducing efficient knockdown for Survivin protein to 6.1%. In addition, PEI@Cdots complexes
mediated Survivin silencing, the arrested cell cycle progression in G1 phase as well as cell apoptosis was observed.
Conclusion: The Cdots-based and PEI-adsorbed complexes both as imaging agents and siRNA nanocarriers have
been developed for Survivin siRNA delivery. And the results indicate that Cdots-based nanocarriers could be utilized in
a broad range of siRNA delivery systems for cancer therapy.
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Over recent decades, great advances have been made in
the combination of nanotechnology and medicine, which
is paving the way towards the goal of clinic application
[1,2]. A large amount of biocompatible fluorescence nano-
materials, such as quantum dots, metal nanoclusters, and
fluorescent polymers, have been developed [3-5]. Carbon
dots (Cdots) are currently emerging as a class of promising
fluorescent probe on account of their low photobleaching,
no optical blinking, tunable photoluminescence, versatile
surfaces, and excellent biocompatibility [6,7]. Therefore,* Correspondence: gxshen@sjtu.edu.cn; dxcui@sjtu.edu.cn
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unless otherwise stated.fluorescent Cdots possess additional benefits over organic
fluorophores and semiconductor quantum dot, which are
more or less circumscribed by their photobleaching or in-
trinsic potential hazards of heavy metal elements (e.g. Cd
and Pb) [8]. These excellent properties of Cdots have made
bright prospects in the applications of bioimaging, drug
delivery, biochemical detection, and sensors [9-11]. Cur-
rently, intensive research has been focus on the synthesis
of Cdots with high quantum efficiency and the construc-
tion of multifunctional systems based on Cdots [10,12,13].
Until now, various precursors including graphite, C60,
citric acid, glucose, and silk have been developed for the
preparation of Cdots with a wide variety of approaches,
processes, and tools [10,12,14-16]. Sun’s group has re-
ported a new strategy to prepare core-shell dots based
on Cdots doped with inorganic salts with quantum yield
around 45% ~ 60%, but the preparation process is quite
complicated [17].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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route for Cdots with high quantum yield around 24.2%
using Ribonuclease A (RNase A) as an assisting and pas-
sivating reagent via microwave assisted one step proced-
ure [18]. Interestingly, the RNase A@Cdots can effectively
inhibit the survival rate of cancer cells. But the price of
RNase A is not economic enough. Taking into account
the mechanism of the photoluminescence (PL) enhance-
ment in RNase A@Cdots, electron-donating effect from
neighbor amino acids especially those with benzene rings
could play an important role. Therefore, we select trypto-
phan (Trp), a kind of amino acids with benzene ring while
possesses a higher nitrogen content than tyrosine and
phenylalanine, for the synthesis of Cdots with lower cost.
Besides, we have ever developed a new theranostic plat-
form based on photosensitizer-conjugated Cdots with
excellent imaging and tumor homing ability for NIR
fluorescence imaging guided photodynamic therapy
[19]. However, till now few reports are closely associated
with the using of Cdots as gene transfection vector for
cancer therapy.
RNA interference (RNAi) has emerged as a valuable
research tool to downregulate the expression of specific
target proteins in a wide variety of cells [20]. RNAi is a
biological process in which RNA molecules inhibit gene
expression by causing the destruction of specific mRNA
molecules. Viral delivery such as Lentivirus, Adenovirus
and Adeno-Associated-Virus, has successfully been used
for therapeutic applications, including cancer therapy
[21,22]. To deal with concerns over the potential risk of
undesired immune and toxic side reactions in virus-
mediated nucleic acid delivery systems, non-viral gene
delivery systems based on inorganic nanoparticles, cat-
ionic liposomes, and cationic polyamidoamine dendrimers
have been employed as carriers for gene silencing [23-25].
The nanomaterials-based non-viral gene delivery systemsFigure 1 Schematic illustration of the formation of Cdots and the Cdohave benefited from many advantages over viral vectors,
as they are simple to prepare, rather stable, easy to mod-
ify and relatively safe. Meanwhile, Cdots would be an
ideal nanocarrier due to the high biological safety, well-
defined structures together with their tunable surface
functionalities.
In this work, the Cdots-based and PEI-adsorbed nano-
carrier (Cdots@PEI) was developed to delivery siRNA
against antiapoptotic protein Survivin in human gastric
cancer cell line MGC-803. It is well known that Survivin
play an important role in cell division, apoptosis, and
checkpoint mechanisms of genomic integrity [26,27]. In
addition, Survivin expression is often upregulated in hu-
man cancers, as it can be treated as a specific tumor
marker with prognostic and therapeutic implications
from studies of gastric carcinomas [28]. For the prepar-
ation of the Cdots-based nanocarrier, firstly, the Cdots
was directly synthesized via microwave pyrolysis of citric
acid in the presence of tryptophan and purified by gradi-
ent centrifugation and dialyzed with MWCO 3500 dialy-
sis bag for 72 h. Secondly, the Cdots@PEI complexes
were formed by electrostatic interaction between negatively
charged Cdots and positively charged PEI (as depicted in
Figure 1). The Cdots@PEI complexes were used to mix
with Survivin siRNA (siRNA-Cdots@PEI). Afterwards, we
investigated gene transfection efficacy, cellular uptake, and
biological effects of the siRNA-Cdots@PEI complexes to-
wards gastric cancer cells MCG-803 by means of reverse
transcription polymerase chain reaction (RT-PCR), Western
blotting, apoptosis assay and cell cycle analysis. The results
showed that siRNA can attach to the surface of the Cdot-
s@PEI complexes and notably enhanced the gene delivery
efficiency. The system renders the possibility of Cdots to
serve as a universal transmembrane carrier for intracellu-
lar gene and drug delivery and imaging applications in
cancer gene therapy.ts-based nanocarrier for the delivery of siRNA.
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Materials
Citric acid, L-tryptophan (99%) and polyethylenimine
(PEI) with a molecular weight of 1800 Da were purchased
from Aladdin Reagent Co. Ltd. (Shanghai, China). Di-
methyl sulfoxide (DMSO) was obtained from Sinopharm
Chemical Reagent Co., Ltd, China. Hieff™ qPCR SYBR®
Green Master Mix and Annexin V-FITC/PI Apoptosis
Detection Kit were purchased from Yeasen Corporation
(Shanghai, China). 3-[4, 5-dimethylthiazol-2yl]-2,5-
diphenyltetrazolium bromide (MTT) was purchased from
Invitrogen Corporation (Carlsbad, CA, USA). Random
primer and M-MLV reverse transcriptase were purchased
from Promega (Madison, WI, USA). RIPA lysis buffer and
BCA (bicinchoninic acid) protein assay kit were purchased
from Beyotime Biotechnology (Jiangsu, China). Monoclonal
rabbit anti-Survivin antibody, polyclonal rabbit anti-β-actin
antibody, and horseradish peroxidase (HRP)-conjugated
goat anti-rabbit IgG were purchased from Epitomics
(Burlingame, CA, USA). Complete protease inhibitor
cocktail and BM Chemiluminescence Western Blotting
Kit were obtained from Roche (Mannheim, Germany).
Human gastric cancer MGC-803 cells and human gastric
mucous epithelial GES-1 cells were available in the Cell
Bank of Type Culture Collection of Chinese Academy of
Sciences. Cell culture products and reagent were pur-
chased from GIBCO. All the above chemicals were used
without any further purification. Ultrapure water (Millipore
Milli-Q grade) with a resistivity of 18.2 MΩ cm was used
in all the preparations.
Synthesis and characterization of Cdots and Cdots@PEI
The luminescent Cdots was synthesized by a one-step
green route of microwave assisted pyrolysis method.
Briefly, 2 g citrate and 0.01 g L-Trp was dissolved in
30 ml of ultrapure water, and stirring for 1 h to form a
homogeneous solution in a 100 ml beaker. Then the
beaker containing clear transparent solution was placed
at the center of the rotation plate of a domestic micro-
wave oven (700 W) and heated for 3 minutes. When
cooled down to room temperature, the Cdots were iso-
lated from the opaque suspension via centrifugation with
10,000 rpm which aims at removing carbon residual. Ex-
cessive citric acid and L-Trp were removed via repeated
dialysis against deionized water using a low molecular
weight cut-off membrane (1000 Da) for 2 days. Finally,
different concentration can be got through rotary evap-
oration, which is used to remove water as it depends.
The morphologies of the Cdots were detected using a
transmission electron microscope (TEM, 2100F, JEOL,
Japan), operating at an accelerated voltage of 200 kV.
Photoluminescence (PL) spectra were measured on a
Hitachi FL-4600 spectrofluorometer. UV–vis spectra were
recorded with a Varian Cary 50 spectrophotometer(Varian Inc., Palo Alto, CA, USA). X-ray diffraction (XRD)
measurement was performed with a D8 Advance (Bruker
AXS Corporation, Germany). Fourier transform infrared
(FTIR) spectra were conducted on a Nicolet 6700 spec-
trometer (Thermo Electron Corporation, Madison, WI)
using KBr pellets. X-ray photoelectron spectrum (XPS)
was acquired with a Kratos Axis UltraDLD spectrometer
(AXIS Ultra, Kratos Analytical Ltd, Japan) using a mono-
chromatic Al Kα source (1486.6 eV). Zeta potential was
completed using a NICOMP 380 ZLS Zeta potential/Particle
sizer (PSS Nicomp, Santa Barbara, CA, USA) equipped
with a He-Ne laser (λ = 633 nm).
Quantum yield measurement
The quantum yield of the Cdots was determined using
quinine sulfate in 0.1 M H2SO4 (quantum yield: 54%) as
the standard sample. According the emission peak area
and absorbance of Trp@Cdots and quinine sulfate, the
QY of the Trp@Cdots could be calculated from Equation 1
below:







Where Φstd is the known quantum yield of the standard
compound, Fsample and Fstd are the integrated areas of
fluorescence of the sample and standard in the emission
region at 350–600 nm. Astd and Asample are the absorbance
of the standard and sample at the excitation wavelength
(360 nm); n is the refractive index of solvent, for water the
refractive index is 1.33, 0.1 M H2SO4 is 1.33. All samples
were diluted to ensure the optical densities less than 0.10
measured by Varian Cary 50 UV–vis spectrophotometer
to minimize re-absorption effects.
Preparation of siRNA-Cdots@PEI complexes and agarose
gel electrophoresis
Three couples of siRNA oligonucleotides (noted as Surv-1,
Surv-2 and Surv-3, respectively) and a couple of non-
silencing-siRNA as negative control (NC) oligonucleotides
were chemically synthesized by Shanghai Genechem Co.
All siRNAs were annealed with complementary antisense
strands with 3′-dTdT overhangs. The siRNA duplexes are
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(dTdT)-3′; antisense, 5′-ACGUGACACGUUCG
GAGAATT(dTdT)-3′.
The Cdots-based complexes were formed by electro-
static interactions between positively charged PEI and the
negatively charged Cdots, and then the negatively charged
phosphate backbone of siRNA attaching to the Cdots@PEI
complexes, resulting the siRNA loaded siRNA-Cdots@PEI
complexes. The Cdots@PEI and siRNA-Cdots@PEI com-
plexes were purified by gel filtration over a Sephadex G-50
column equilibrated with 10 mM NaCl to remove un-
adsorbed PEI or siRNA. The electrophoretic mobility of
the siRNA-Cdots@PEI complexes was determined by 1%
agarose gel in 1× TBE buffer with a constant voltage of
120 V for 20 min. The siRNA loading amount was deter-
mined by measuring the absorption at 260 nm using the
relation 1OD duplex = 3.0 nmols after subtracting the ab-
sorbance contributed by Cdots@PEI at the same wave-
length. In aqueous solution of pH 7.4, the concentration of
siRNA was determined to be about 15 nM when the con-
centration of Cdots@PEI was 100 μg/ml. All data when
used for siRNA-Cdots@PEI complexes were expressed as
100 μg/ml Cdots@PEI with about 15 nM siRNA, unless
otherwise specified.
Cell culture and MTT assay
Human gastric cancer MGC-803 cells and human gas-
tric epithelial GES-1 cells were available in the Cell Bank
of Type Culture Collection of Chinese Academy of Sci-
ences. All the cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) plus 10% (vol/vol) fetal bovine
serum (Gibco) and penicillin-streptomycin (100 U/ml to
0.1 mg/ml) and incubated in a humidified incubator
containing 5% CO2 at 37°C. MTT assay was carried out
to investigate the cytotoxicity of Cdots and Cdots@PEI.
MGC-803 and GES-1 cells were first seeded to 96-well
plates at a seeding density of 5 × 103 cells per well in
100 μl complete medium, which was incubated at 37°C
for 24 h. Then the culture medium in each well was re-
placed by 100 μl fresh complete medium containing serial
concentrations of Cdots and Cdots@PEI. After incubation
for 24 h, the medium was replaced with 150 μL fresh
medium containing 15 μl MTT (5 mg/ml in PBS) and in-
cubated for another 4 h. Afterwards, the culture medium
with MTT was removed and 150 μl/well of DMSO was
added, followed by shaking for 10 min at room temperature.
The absorbance of each well was measured at 490 nm
using a standard micro plate reader (Scientific Multiskan
MK3, thermo, USA). The cell viability was calculated ac-
cording to the equation: cell viability = (OD490 nm of the
experimental group/OD490 nm of the control group) ×
100% and the cell viability of control group was denoted
as 100%.In vitro siRNA transfection and cellular uptake of
siRNA-Cdots@PEI complexes
Before transfection, the MGC-803 cells were seeded in
6-well plates and the appropriate transfected number of
cells is based on the fact that confluent of cells achieve
to 30% to 50% at the time of transfection. Each sample
prepared siRNA oligo-Cdots@PEI complexes are as fol-
lows: A. siRNA oligo stock solution was diluted to 1 μM
before transfection. Then 110 μl 1 μM of siRNA oligo
was added to 200 μl serum-free DMEM and mix gently
at room temperature for 5 min. B. After incubated for
5 min, 100 μl Cdots@PEI are taken into diluted siRNA
oligo (mentioned in a.) with immediate shaking (using a
scroll instrument or pipetting more than 10 s). After
mild centrifugation, the solution needs to stand still at
room temperature for 10 min, to allow the effective for-
mation of siRNA oligo-Cdots@PEI complexes. C. While
it is incubated, the medium in the cell culture plates
need to be refreshed. Each well was added 1.8 ml of
complete medium (containing 10% serum and antibi-
otics). The siRNA oligo-Cdots@PEI complexes were
dropped into each well containing cells and the medium.
Gently shake the culture plate after mixing. Complete
medium can be changed after 4–6 h transfection. Scram-
bled siRNA with the transfection reagent of Cdots@PEI
was used as the nontargeting control. After incubation
with different transfection complexes for 48 h, approxi-
mately 2 × 105 MGC-803 cells were collected from each
sample and then subjected to quantitative reverse
transcription-PCR (qRT-PCR) and Western blot analysis
to determine the silencing efficiency against Survivin
gene and Survivin protein expression. For evaluation of
cellular uptake of siRNA-Cdots@PEI complexes, we
tracked the cellular internalization of Cdots-PEI, Cy3-
labelled siRNA, or Cy3-siRNA-Cdots@PEI in MGC-803
cells. The cells were plated on 14 mm glass coverslips
and allowed to adhere for 24 h. After co-incubation with
Cdots-PEI, Cy3-labelled siRNA, or Cy3-siRNA-Cdots@PEI
for different times, the cells were washed twice with PBS
sufficiently and fixed with 4% paraformaldehyde. Confocal
fluorescence images were captured with a TCS SP5 con-
focal laser scanning microscopy (Leica Microsystems,
Mannheim, Germany). Blue and red fluorescence im-
ages were acquired using DAPI-specific (excitation,
340–380 nm; emission, 450–490 nm) and Cy3-specific
(excitation, 515–560 nm; emission, > 590 nm) sets of fil-
ters, respectively.
Survivin expression assay by qRT-PCR analysis
In qRT-PCR experiment, the total RNA was extracted
from transfected MGC-803 cells using the TRIzol reagent
(Invitrogen, America) according to the manufacturer’s in-
structions. A total of 1 μg of RNA was transcribed into
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transcriptase (Promega). The cDNA templates were
stored at −20°C. The qRT-PCR was performed in a
final volume of 25 μl containing 12.5 μl of Hieff™ qPCR
SYBR® Green Master Mix (Yeasen, Shanghai), and 1 μl
of each 10 μM primer, and 1 μl of 1:10-diluted cDNA
products. The PCR amplification was carried out in a
Bio-Rad iQ5 with one cycle at 95°C for 5 min, followed
by 30 cycles at 95°C for 30 sec, at 67°C for 30 sec, and
at 72°C for 1 min, and finally at 72°C for 5 min. GAPDH
was chosen as the endogenous control in the assay. The
following PCR primers were used: GAPDH primers,
forward: 5′-CCACCCATGGCAAATTCCATGGCA-3′,
reverse: 5′-TCTATCTAGACGGCAGGTCAGGTCCA
CC-3′; Survivin primers, forward: 5′-GTGAATTTTT
GAAACTGGACAG-3′, reverse: 5′-CCTTTCCTAAGA
CATTGCTAA-3′.Western blot analysis
MGC-803 cells were lysed at 72 h after the transfection
using RIPA lysis buffer (20 mM Tris, pH 7.5, 150 mM
NaCl, 1% Triton X-100, 2.5 mM sodium pyrophosphate,
1 mM EDTA, 1% Na3VO4, 0.5 μg/ml leupeptin, and
1 mM phenylmethanesulfonyl fluoride) in the presence
of complete protease inhibitor cocktail (Roche Diagnostics).
The homogenate was then subjected to 10,000 rpm cen-
trifugation for 10 min at 4°C. All the above procedures
were performed in ice bath. The protein concentration
was determined using BCA (bicinchoninic acid) protein
assay kit (Beyotime Biotech, Jiangsu, China) and store at
−20°C. The cell extracts (20 μg total proteins) were
mixed with four times loading buffer (16% glycerol, 20%
mercaptoethanol, and 2% SDS, and 0.05% bromophenol
blue) (3:1, sample/loading buffer) and boiled for 5–7 min
at 100°C. The samples were then subjected to 12% sodium
dodecyl sulfate poly-acrylamide gel electrophoresis (SDS-
PAGE) at 120 V for 1 h and then transferred onto
0.45 mm polyvinylidene difluoride membrane (PVDF,
Immobilon-P 0.45 μm, Millipore, Billerica, MA), using
a semi-dry system (Biocraft, Tokyo, Japan) at 300 mA
for 150 min. Membranes were blocked with Tris-buffered
saline containing 0.1% Tween 20 and 5% dry skim milk
powder and then incubated with rabbit anti-human survi-
vin antibody (1:1000, Epitomics) and rabbit anti-human β-
actin antibody (1:2500, Epitomics) at 4°C overnight with a
gentle shaking. The next day, after four 5 min washes with
TBST buffer, the bolts were then incubated with horserad-
ish peroxidase (HRP)-conjugated secondary antibody
(goat anti-rabbit IgG, 1:2500, Epitomics) for 1 h at room
temperature. Antibody binding was detected by enhanced
chemiluminescence (BM Chemiluminescence Western
Blotting kit, Roche) and autora-diography (Kodak X-
OMAT; Kodak, Rochester, NY).Apoptosis assay by Annexin V-FITC and propidium iodide
(PI) staining
The apoptotic and necrotic cells were analyzed by
Annexin V/PI apoptosis detection Kit (Yeasen) accord-
ing to the manufacturer’s protocol. In brief, MGC-803
cells were seed in 6-well plates at 5 × 104 cells/well for
24 h before co-incubated with Surv-1-Cdots@PEI, Surv-
2-Cdots@PEI, Surv-3-Cdots@PEI, NC-Cdots@PEI, and
Cdots@PEI complexes, respectively. The cells incubated
with complete medium only were set as blank control.
After 48 h incubation, the cells were harvested, washed
with PBS and re-suspended in 200 μL of binding buffer
containing 5 μL Annexin V and 10 μL PI. After incubation
in dark at room temperature for 15 min, 400 μL of bind-
ing buffer was added to each sample, and the cells were
immediately analyzed by FACSCalibur (BD Biosciences,
Mountain View, CA). The data analysis was performed
with Flow Jo 7.6 software. Positioning of quadrants on
Annexin-V/PI plots was performed to distinguish living
cells (Annexin V−/PI−), early apoptotic cells (Annexin
V+/PI−), late apoptotic/necrotic cells (Annexin V+/PI+).
Cell cycle analysis
Cell cycle analysis was performed using Flow cytometry.
After the incubation of MGC-803 cells with Surv-1-
Cdots@PEI, Surv-2-Cdots@PEI, Surv-3-Cdots@PEI,
NC-Cdots@PEI, and Cdots@PEI complexes for 48 h,
respectively, cells were harvested, washed with PBS
and fixed overnight in 70% ethanol at −20°C. Then the
cells were washed with PBS and stained with 50 μg/ml
PI and 100 μg/ml RNase A for 30 min in the dark at room
temperature. The cell cycle phase distribution was ac-
quired by FACSCalibur and G1, S, and G2/M populations
were quantified using FlowJo 7.6 software.
Result and discussion
Synthesis and characterization of Cdots
The morphology and structure of the Cdots were charac-
terized by HRTEM and XRD. The HRTEM images indi-
cate that the Cdots have outstanding uniform sizes and
spherical shape, with an average diameter of about 2.6 nm
(Figure 2a). The XRD pattern measured for Cdots shows a
broad peak located at 2θ of around 20°(d = 4.2 Å), which
is consistent with the (002) lattice spacing of Graphite,
meanwhile, the larger interlayer spacing of 4.2 Å com-
pared to that of bulk graphite which is about 0.33 nm
might have resulted from the poor crystallization [7]. As
shown in Figure 2c insets, the final product of Cdots is
brownish in aqueous solution and emitted intensive blue
luminescence under excitation of 365 nm UV light. The
UV–vis absorption spectrum of the Cdots shows a clear
an absorption feature at about 280 nm, which is ascribed
to the function of aromatic rings of Tryptophan. The emis-
sion of the Cdots depends on the excitation wavelength.
Figure 2 Characterization of the as-synthesized Cdots (a) HRTEM images and inset is the zoom of particles. (b) XRD pattern of the Cdots.
The spherical Cdots are marked by circles. (c) UV–vis absorption spectrum of the Cdots, insets are digital photos of the Cdots dissolved in water
under white-light (left) and UV (365 nm) excitation (right). (d) PL spectra of the Cdots when excited at different wavelengths from 320 to 460 nm
in a 20 nm increment.
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excitation wavelength of 360 nm, with the highest quantum
yield of 20.6%. XPS measurement was performed for the
characterization of surface states (Figure 3). Three bands of
the XPS survey spectrum at around 531.5, 400.0, and
284.5 eV represent O1s, N1s, and C1s, respectively, which
indicating the atomic ratio of O/N/C is 54.6/3.6/41.8 as cal-
culated from the survey spectrum [7,10]. The C1s core level
spectrum can be deconvoluted into three contributions at
284.6, 285.2, and 289.0 eV, which are associated with car-
bon in the states of C-C, C-N, and O-C =O, respectively
[7,9]. The O1s peaks at 532.0 and 533.2 eV can be assigned
to oxygen in the form of C =O and C-O-C/C-OH, respect-
ively [7,12]. The N1s peaks at 399.5 and 401.2 eV suggest
that nitrogen exists mostly in the forms of (C)3-N and N-H,
respectively [7,13]. Furthermore, Fourier transform infrared
(FTIR) spectral measurement was conducted to determine
the surface state of Cdots. As shown in Additional file 1:
Figure S1, the as-synthesized Cdots show a main absorp-
tion band of O-H/N-H stretching vibration from 3630–
2820 cm−1 and the existence of carbonyls (C =O) at
1717 cm−1. The bending vibration of C-O/C-N band and
stretching peak of the C-O-C bond appear at 1400 cm−1
and 1194 cm−1, respectively [9,16,17]. In brief, the as-
synthesized Cdots are rich in oxygen and possess mounts
of hydroxyl/amine and carboxyl groups, which is useful for
further modifications and biological applications.Formation and characterization of Cdots@PEI and
siRNA-Cdots@PEI complexes
The suspension of as-synthesized Cdots was highly stable
in aqueous solution, with a zeta potential of −18.9 ±
1.2 mV at pH 7.4, imparting sufficient colloidal stability
to the Cdots. Undoubtedly, it’s necessary to further ex-
change exterior charge of the Cdots for the siRNA deliv-
ery. So we introduce PEI, which have been reported to
be individually considered as nonviral gene carriers with
a capability of forming stable complexes by electrostatic
interactions with nucleic acids. The zeta potentials of
the as-prepared Cdots@PEI and siRNA-Cdots@PEI
complexes were 26.6 ± 1.6 and 12.7 ± 0.8 mV, respect-
ively, indicating the successful attachment of siRNA and
PEI to the Cdots (Figure 4a). It is noteworthy that even
after the load of siRNA; the positively charged siRNA-
Cdots@PEI complexes could be conducive to intracellular
delivery. The hydrodynamic particle size of siRNA-
Cdots@PEI complexes was 4.7 ± 0.8 nm, which was a little
larger than that of Cdots (3.9 ± 0.3 nm) (Figure 4b). The
results of zeta potentials and hydrodynamic diameters in-
dicated the favorable dispersibility of Cdots@PEI and
siRNA-Cdots@PEI complexes in aqueous solution. Fur-
thermore, agarose gel electrophoresis assay was taken to
evaluation of capability of the Cdots@PEI complexes.
With the attachment of negative charged siRNA, the sur-
face positive charge of siRNA-Cdots@PEI complexes was
Figure 4 Characterization of the Cdots@PEI and siRNA-Cdots@PEI complexes. (a) Zeta potential of the Cdots, Cdots@PEI and siRNA-Cdots@PEI
complexes. (b) Hydrodynamic diameters and (c) agarose gel electrophoresis analysis of the Cdots and siRNA-Cdots@PEI complexes. There were four paralleled
loadings of each example at same time. (d) Cell viability of MGC-803 cells after treatment of different concentrations of Cdots and Cdots@PEI complexes.
Figure 3 XPS spectra of the Cdots. (a) Survey spectrum of the Cdots with three major peaks of carbon, oxygen, and nitrogen. XPS high
resolution survey spectra of (b) C1s, (c) O1s, and (d) N1s region of Cdots.
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which caused the opposite direction of migration and the
lower electrophoretic mobility when compared with Cdots
(Figure 4c). Before the applications of the Cdots-based
nanocarrier, the cell toxicity of Cdots and Cdots@PEI
complexes was evaluated using MTT assays. Figure 4d
showed the comparative viability of the cells incubated
with Cdots and Cdots@PEI. It was found that Cdots in-
duced no change in the cell viability when the dose was
up to 400 μg/ml, suggesting their excellent biocompati-
bility. Previous reports have shown that the high con-
tent of cationic amine groups in branched polymer PEI
mediated the substantial cytotoxicity [29]. The cell via-
bility of MGC-803 cells was not seriously influenced byFigure 5 Confocal laser scanning microscopic images of MGC-803 cells in
complexes for 2 and 5 h.the addition of Cdots@PEI complexes, as it only slightly
decreased to 87.2%. In this regard, the reduced cytotox-
icity of Cdots@PEI can be explained by the reduced
amounts of primary amine groups exposed at the sur-
face of Cdots@PEI complexes.
Intracellular delivery of siRNA by Cdots@PEI complexes
As known to all, the negatively charged siRNA alone
was inhibited from cellular uptake due to its inability to
cross cellular membranes [24,25]. Herein, the positively
charged siRNA-Cdots@PEI complex was proposed to
enhance the cellular uptake and delivery of siRNA intracel-
lularly. The resulting complex was used to transfect MGC-
803 cells at pH 7.4 for 2 and 5 h, and the cells treated withcubated with Cdots@PEI or Cy3-siRNA for 2 h, Cy3-siRNA-Cdots@PEI
Figure 6 Gene silencing efficiency of siRNA-Cdots@PEI complexes against Survivin at (a) mRNA and (b) protein expression level.
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new fluorescent nanoprobe, the application of Cdots for
bioimaging and biolabeling in cancer cells was evaluated.
Fluorescence images were acquired using DAPI- and Cy3-
specific sets of filters for the blue and red channels of
fluorescence, respectively. As shown in Figure 5, after incu-
bation with the Cdots@PEI complexes for 2 h, bright blueFigure 7 Apoptosis induction in MGC-803 cells by siRNA-Cdots@PEI c
untreated, mock transfection, and negative control groups, respectively. (d-
complexes-carried siRNA (Surv-3, Surv-2, and Surv-1) for 48 h, respectively.fluorescence was distributed in the cytoplasm while dim
red fluorescence was observed. Consistent with the above
excitation-dependent fluorescence, the intensity of red
fluorescence excited from green light was much weaker
than that of blue fluorescence excited from UV light. As
anticipated, even after incubation with Cy3-siRNA for 5 h,
only a marginal level of red fluorescence was detectedomplexes mediated Survivin RNAi. (a-c) Apoptosis analysis of
f) Apoptosis analysis of MGC-803 cells treated with Cdots@PEI
Figure 8 Flow cytometry analysis of cell cycle arrest in MGC-803 cells induced by siRNA-Cdots@PEI complexes mediated Survivin
downregulation. (a-c) Cell cycle phase distribution of MGC-803 cells in untreated, mock transfection, and negative control groups, respectively.
(d-f) Cell cycle phase distribution of MGC-803 cells treated with Cdots@PEI complexes-carried siRNA (Surv-3, Surv-2, and Surv-1) for
48 h, respectively.
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that has entered the cells. In contrast, the siRNA-
Cdots@PEI complex was rapidly accumulated into the
MGC-803 cells within 2 h. With time growing, blue fluor-
escence from Cdots and red fluorescence from siRNA in-
crease significantly at a time dependent manner. Hence, it
is conceivable that the positively charged Cdots@PEI com-
plexes play an important role in the great enhancement of
siRNA internalization. The results indicated that the fluor-
escent Cdots-based siRNA delivery system not only can
be efficient nanocarrier but also intracellular distribution
reporter.
Gene silencing efficiency of siRNA-Cdots@PEI complexes
Real-time PCR and Western blot assay was performed to
evaluate the gene silencing efficiency of siRNA-Cdots@PEI
complexes on the mRNA and protein level, respectively.
The GAPDH was selected as a reference gene. The Cdot-
s@PEI complexes functionalized with nontargeting scram-
bled siRNA served as a negative control. Compared with
the blank control group (untreated), the expression level of
Survivin mRNA was reduced to 19.3 ± 1.2%, 29.7 ± 1.8%,38.2 ± 2.3%, 95.3 ± 6.9%, and 96.4 ± 8.7 when the cells
were transfected with Surv-1-Cdots@PEI complexes,
Surv-2-Cdots@PEI complexes, Surv-3-Cdots@PEI com-
plexes, scrambled siRNA-Cdots@PEI complexes (negative
control), and Cdots@PEI complexes (mock transfection),
respectively (Figure 6a). The effect of Cdots@PEI
complexes-based siRNA delivery on Survivin protein
down-regulation was evaluated after 72 h of treatment.
As shown in Figure 6b, the expression levels of protein
of test group, Survivin in MGC-803 cells exhibited
gradually down-regulation compared with the control
groups, and the group of Surv-1-Cdots@PEI com-
plexes exhibited the strongest inhibition effect on ex-
pression of Survivin protein, which corresponded well
with the data given by qRT-PCR.
Apoptosis assay and cell cycle analysis
In order to determine the secondary effects on the con-
text of cell physiology by the downregulation of Survivin
protein, the apoptosis levels and cell cycle distributions
were evaluated based on flow cytometry analysis. Since
Survivin inhibits apoptosis and improves the proliferation
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siRNA-Cdots@PEI complexes in MGC-803 cells could in-
duce apoptosis. Using Annexin V-FITC/PI double staining
and flow cytometric analyses, rates of apoptosis were
quantified as sums of early and late apoptotic cells. As
shown in Figure 7a-c, the cells in blank (a), negative con-
trol (b), and mock (c) groups showed a large viable cell
population with very fewer staining for early apoptotic,
late apoptotic and necrosis cells, respectively. However,
MGC-803 cells treated with Cdots@PEI complexes-
carried siRNA (Surv-3, Surv-2, and Surv-1) for 48 h re-
sulted in a shift from live cells to early apoptotic, late
apoptotic, and dead cell populations (Figure 7d-f). Quanti-
tative analysis of the data clearly demonstrated that Surv-
3, Surv-2, Surv-1 traetment for 48 h resulted in 9.82%,
10.2%, and 15.2% early apoptotic cells; 2.50%, 3.98%, and
7.69% of late apoptotic cells, respectively. However, the
dead cells also increased. It is widely accepted that cell
cycle progression can be either negatively or positively
regulated by a number of dynamically expressed genes.
Previous studies have suggested that Survivin participates
in multiple facets of cell division via controlling micro-
tubule stability of the normal mitotic spindle [27,30].
Therefore, secondary effect was further extended to cell
cycle analysis by propidium iodide (PI) staining-based flow
cytometry cell cycle assay. As shown in Figure 8a-c, there
was no significant change in cell cycle distribution in the
cells treated with Cdots@PEI complexes (mock group) or
scrambled siRNA-Cdots@PEI complexes (negative control
group) when compared with the untreated cells (untreated
group). However, the cells treated with Cdots@PEI
complexes-carried siRNA (Surv-3, Surv-2, and Surv-1)
demonstrated an increase in cell population in G1 phase,
indicating that knockdown of Survivin could block the
G1/S transition (Figure 8d-f). Therefore, we hypothesized
that the critical role of Survivin in early cell cycle entry
would explain cell cycle arrest MGC-803 cells when Survivin
was down-regulated.
Conclusion
In summary, the Cdots-based and PEI-adsorbed com-
plexes both as imaging agent and siRNA nanocarrier
have been developed for Survivin siRNA delivery. The
Cdots were prepared via one-step microwave assisted
approach with citric acid as carbon source and trypto-
phan as passivation agent and nitrogen source. The as-
synthesized Cdots exhibited excellent water dispersibility,
biocompatibility, and high quantum yield. In the elabor-
ately fabricated complexes of siRNA-Cdots@PEI, Cdots
acted as a nanocarrier and a fluorescent indicator, while
the positively charged PEI acted as the ties attaching nega-
tive charged siRNA to Cdots. Furthermore, the confocal
fluorescence images indicted the cellular uptake of siRNA-
Cdots@PEI complexes, and subsequently qRT-PCR andWestern blot analysis confirmed the successfully entrance
of siRNA into MGC-803 cells and superior gene silencing
efficiency. Importantly, the siRNA-Cdots@PEI complexes,
which target Survivin gene, can induce apoptosis and
cell cycle arrest in G1 phase inhuman gastric cancer
cells MGC-803. The resulting Cdots-based delivery system
may be used to advance the field of siRNA therapeutics.
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